Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$28.15 +0.76 (+2.79%)
As of: Nov 11, 2026 · 2:14 PM EST

Arcutis Biotherapeutics (ARQT) Cash & Equivalents (2018 - 2026)

Updated

Arcutis Biotherapeutics (ARQT) recorded Cash & Equivalents of $107.47 million in Q3 2023, up 31.8% from $81.54 million a year earlier and up 2.2% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Cash & Equivalents (2018 - 2026) Analysis & Trends

At the end of FY2022, Arcutis Biotherapeutics reported Cash & Equivalents of $53.64 million, down 44.4% from FY2021.

  • Annual Cash & Equivalents has a three-year compound annual growth rate of -5.4% (FY2019 to FY2022).
  • Across earlier years, Cash & Equivalents came in at $96.45 million in FY2021 (+48.2%), $65.08 million in FY2020 (+2.8%) and $63.34 million in FY2019.
  • The Q3 2023 figure is the highest quarterly Cash & Equivalents since Q1 2021.
  • On a year-over-year basis, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 9.2% over the last eight quarters.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 70.9% in Q2 2023, against a decline of 75.8% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $105.11 million (Q2 2023), $81.41 million (Q1 2023) and $53.64 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn 33.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 33.37 Mn
Jun 30, 2026 34.12 Mn
Mar 31, 2026 34.76 Mn
Dec 31, 2025 42.91 Mn
Sep 30, 2025 47.12 Mn
Jun 30, 2025 72.74 Mn
Mar 31, 2025 53.10 Mn
Dec 31, 2024 71.34 Mn
Sep 30, 2024 134.85 Mn
Jun 30, 2024 84.27 Mn
Mar 31, 2024 190.10 Mn
Dec 31, 2023 88.40 Mn
Sep 30, 2023 107.47 Mn
Jun 30, 2023 105.11 Mn
Mar 31, 2023 81.41 Mn
Dec 31, 2022 53.64 Mn
Sep 30, 2022 81.54 Mn
Jun 30, 2022 61.51 Mn
Mar 31, 2022 69.80 Mn
Dec 31, 2021 96.45 Mn
API Access

Arcutis Biotherapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARQT&period=max&api_key=YOUR_API_KEY